Lung Cancer Alliance.
Keystone, et al Abstract 2228; Poster Session; 8 November, 2011; 9 a.m.m.; Area: Poster HallPhase 3b and Post-Marketing Observational Study Linked to Safety and Performance of Adalimumab in Sufferers with Rheumatoid Arthritis During More Than Five Years of Therapy; G. Burmester, et al Abstract 2216; Poster Program; November 8, 2011; 9 a.m.m.; Area: Poster HallJuvenile Idiopathic Arthritis Study Related to Long-Term Efficacy and Security of Adalimumab for up to Six Years in Sufferers with Juvenile Idiopathic Arthritis; D. Lovell, et al Abstract 265; Poster Program; November 6, 2011; 9 a.m.m.; Location: Poster Hall Ankylosing Spondylitis/Spondyloarthritis Five-Year Results Related to Improvement of Spinal Flexibility, Physical Quality and Function of Life in Patients with Ankylosing Spondylitis; D.